Laurate-bioconjugated fructans could be useful to counteract the adverse effects of a high-fat diet on the characteristics of MetS such as obesity, insulin resistance, high blood pressure, and hypertriglyceridemia, probably by decreasing food intake and modulating CRP and IL-10. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.